Keyword: Dede Willams

News

Pfizer Merges Upjohn With Mylan

30.07.2019 - New York-based US drugs giant Pfizer is merging its off-patent franchise, Upjohn, with generics specialist Mylan. The deal announced on Jul. 29 and expected to close in mid-2020...

News

Damages Reduced in Third Roundup Verdict

29.07.2019 - A third judge has slashed a jury’s damage award to a plaintiff in a lawsuit involving Monsanto’s glyphosate-based Roundup herbicide. The award reduced last week by Judge Winifred...

News

Qixiang Tengda Chemical to Build PO Plant in China

29.07.2019 - German chemical producer Evonik and compatriot engineering contractor Thyssenkrupp Industrial Solutions will license Evonik’s hydrogen peroxide-to-propylene oxide (HPPO) Technology...

News

Clariant Makes Waves With a Triple Shock

26.07.2019 - For two days this week, Clariant dominated European business and stock market news. After dropping the first bombshell on Wednesday (Jul. 24) that its CEO, Ernesto Occhiello, had...

News

Sanofi Buys Nonprescription Rights to Tamiflu

25.07.2019 - Under an exclusive deal with Roche, French drugmaker Sanofi has secured non-prescription rights to the Swiss pharmaceutical giant’s now off-patent influenza drug Tamiflu in the US...

News

Market Speculates on Clariant CEO’s Resignation

25.07.2019 - On Jul. 24, a day before publishing its financial results for the first half of 2019, Swiss specialty chemicals producer Clariant shocked the markets by announcing the resignation...

News

ADL and Amyris Extend Production Pact Again

24.07.2019 - Leon, Spain-based ADL Bionatur Solutions and Amyris of Emeryville, California, USA, have extended an existing production agreement that foresees ADL producing up to five fermented...

News

Yellow Wood to Buy Dr. Scholl’s from Bayer

23.07.2019 - US private equity group Yellow Wood Partners has agreed to acquire the Dr. Scholl’s footcare business from Bayer for $585 million. Following completion of the transaction in this...